Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. [electronic resource]
Producer: 20160607Description: e0139474 p. digitalISSN:- 1932-6203
- Adult
- Anti-HIV Agents -- therapeutic use
- Antigens, CD -- analysis
- Antiretroviral Therapy, Highly Active
- CX3C Chemokine Receptor 1
- Cell Separation
- Drug Combinations
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination -- therapeutic use
- Female
- Flow Cytometry
- HIV Infections -- blood
- HIV Integrase Inhibitors -- administration & dosage
- HIV-1
- HLA-DR Antigens -- analysis
- Humans
- Immunophenotyping
- Male
- Middle Aged
- Monocytes -- classification
- Raltegravir Potassium -- therapeutic use
- Receptors, CCR2 -- analysis
- Receptors, Chemokine -- analysis
- Viral Load
- Viremia -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.